Notes:

• No data suppression rules are applied to the clinic and country-level data that are accessible through password-protected clinic user accounts. Caution is advised when interpreting data visualizations and trends for small numbers of patients.
• Country-level data are aggregated from patient-level databases at clinics participating in IeDEA, using the IeDEA Data Exchange Standard (DES). These clinics are not nationally representative. Aggregated country-level data that are accessed through password-protected clinic user accounts may differ from data displayed on the public version of the Treat All Dashboard because of differences in exclusion criteria and suppression rules.
• All ART-naïve patients newly enrolling in HIV care since 2010 at clinics that participate in IeDEA were eligible for inclusion if they had at least 15 months between enrollment and database close or transfer to another site of care. The following patients were excluded: patients with incomplete data related to age, sex, and site of enrollment and patients with evidence of ART initiation prior to the date of enrollment.

Definitions:

• Enrollment in HIV care (Newly enrolled): Enrollment in HIV care at a site participating in the IeDEA consortium, based on the date of enrollment recorded in the database.
• Timely ART initiation: Initiation of a combined regimen of antiretroviral therapy (ART) medications within 7 days, 14 days, 30 days, and 12 months after enrollment, or more than 12 months after enrollment.
• Viral load monitoring (VL test recorded): Any record of a viral load test at 6 months (+/- 3 months) and 12 months (+/- 3 months) after enrollment.
• Viral suppression: Viral load <1,000 copies/mL among patients with a recorded viral load test at 6 months (+/- 3 months) and 12 months (+/- 3 months) after the date of enrollment in care at a site participating in IeDEA. Patients with no viral load test result within the ascertainment windows are excluded from viral suppression measures. For patients with >1 viral load test result within the ascertainment window, the lowest recorded viral load measure was used.

Visit the Measures and Methodology page for information about data methods, sources, definitions, and suppression rules.